MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Disentangling postural instability-gait difficulties classification model for the prediction of cognitive impairment in de novo Parkinson’s Disease patients

    D. Urso, V. Leta, L. Batzu, T. Yousaf, C. Farrell, D. van Wamelen, R. Chaudhuri (London, United Kingdom)

    Objective: To investigate whether postural instability/gait difficulties (PIGD) phenotype classification or specific PIGD-related MDS-UPDRS items may predict cognitive impairment in de novo Parkinson’s disease (PD)…
  • MDS Virtual Congress 2020

    GWAS on impulse control disorders in Parkinson’s disease

    S. Bekadar, F.X Lejeune, F. Danjou, M. Vidailhet, M. Anheim, A. Elbaz, G. Alves, O.B Tysnes, A.H Erga, J. Maple-Grodem, A. Brice, J.C Corvol (Paris, France)

    Objective: To identify the genetic factors associated with Impulse control disorders (ICDs) in Parkinson’s disease (PD) patients using a genome-wide approach. Background: ICDs are associated…
  • MDS Virtual Congress 2020

    Rare variants of the LRRK2 gene in the haplotype as one of the potential risk factors for endemic parkinsonism in a small isolated region in the Czech Republic

    P. Kaňovský, K. Kolaříková, R. Vodička, R. Vrtěl, K. Menšíková, T. Bartoníková, M. Procházka (Olomouc, Czech Republic)

    Objective: The aim of the study was to investigate a co-occurence of rare variants in set of genes frequently associated with parkinsonism. Background: The increased…
  • MDS Virtual Congress 2020

    PARK2 p.Ala82Glu variant is not associated with Parkinson’s disease

    L. Milanowski, B. Broadway, F. Fiesel, D. Hoffman-Zacharska, D. Koziorowski, A. Friedman, J. Slawek, O. Ross, W. Springer, Z. Wszolek (Jacksonville, FL, USA)

    Objective: The aim of the study was to analyze potential pathogenicity of the PARK2 p.Ala82Glu mutation, by functional studies of Parkin in the mitophagy paradigm…
  • MDS Virtual Congress 2020

    Is early-onset of levodopa-induced dyskinesia a predictor of GBA mutation? A next-generation sequencing study of young-onset Parkinson’s disease patients in Thailand

    S. Thanprasertsuk, P. Phowthongkum, T. Hopetrungraung, C. Poorirerngpoom, T. Satirapatya, P. Wichit, O. Phokaewvarangkul, K. Vongpaisarnsin, S. Bongsebandhu-phubhakdi, R. Bhidayasiri (Bangkok, Thailand)

    Objective: To examine the prevalence of genetic causes in young-onset Parkinson’s disease (YOPD) patients with levodopa-induced dyskinesia (LID) in Thailand using a next-generation sequencing (NGS)…
  • MDS Virtual Congress 2020

    Characterization of Lewy bodies-induced neurodegeneration and synucleopathy in wild-type mice

    E. Bezard, L. Zhang, X. Yu, X. Sun, Y. Zhang, G. Ran, S. Dovero, M. Persillet, P. Fernagut, B. Dehay, C. Qin (Beijing, China)

    Objective: To investigate the Lewy-body-induced degeneration and synucleopathy in wild-type mice while focusing upon origin of the Lewy bodies. Background: Neurodegenerative diseases, such as Parkinson’s…
  • MDS Virtual Congress 2020

    Loss of CHCHD2 and CHCHD10 disrupts mitochondrial cristae phenocopying patient mutations

    D. Narendra, Y. Liu, X. Huang, D. Nguyen, M. Shammas, B. Wu, E. Dombi, D. Springer, J. Poulton, S. Sekine (Bethesda, MD, USA)

    Objective: Characterization of novel of a novel CHCHD2 (C2) and CHCHD10 (C10) knockout mouse model. Background: Dominant mutations in the mitochondrial paralogs CHCHD2 (C2) and…
  • MDS Virtual Congress 2020

    Predictors of Underlying Neurodegeneration in Drug-Induced Parkinsonism

    W. Aamodt, J. Dubroff, G. Cheng, B. Taylor, S. Wood, J. Duda, J. Morley (Philadelphia, PA, USA)

    Objective: To examine a cohort of Veterans with drug-induced parkinsonism (DIP) using [123I]Ioflupane single photon emission computed tomography (DAT-SPECT) to identify those with nigrostriatal degeneration…
  • MDS Virtual Congress 2020

    Inter-network connectivity dynamics underlie compensatory mechanisms in prodromal Parkinson’s disease

    A. Droby, N. Omer, M. Artzi, D. Ban-Bashat, M. Hutchison, J. Cederbaum, N. Giladi, A. Mirelman, A. Thaler (Tel Aviv, Israel)

    Objective: We aimed to investigate the dynamics of inter-network connectivity among non-manifesting GBA and LRRK2 mutation carriers. Background: The prodromal phase of Parkinson’s disease (PD)…
  • MDS Virtual Congress 2020

    Hyposmia as a biomarker in patients with Parkinson’s disease and atypical Parkinsonism

    S. Kumaran, A. Ankeeta, S. Chaudhary, P. Bhat, V. Goyal (New Delhi, India)

    Objective: To investigate neural correlates associated with olfactory dysfunction using fMRI and EEG in Parkinsonism. Background: Patients with Parkinsonism experience non-motor symptoms during the onset…
  • « Previous Page
  • 1
  • …
  • 136
  • 137
  • 138
  • 139
  • 140
  • …
  • 149
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley